BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castiella A, Zapata E, Lucena MI, Andrade RJ. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease. World J Hepatol 2014; 6(4): 160-168 [PMID: 24799984 DOI: 10.4254/wjh.v6.i4.160] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Mancini GJ, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng D, Pearson GJ, Pope J, Tashakkor AY. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016). Canadian Journal of Cardiology 2016;32:S35-65. [DOI: 10.1016/j.cjca.2016.01.003] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 25.0] [Reference Citation Analysis]
2 Dong Y, Potthoff A, Klinger C, Barreiros AP, Pietrawski D, Dietrich CF. Ultrasound findings in autoimmune hepatitis. World J Gastroenterol 2018; 24(15): 1583-1590 [PMID: 29686465 DOI: 10.3748/wjg.v24.i15.1583] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome. Liver Int 2021. [PMID: 34152686 DOI: 10.1111/liv.14985] [Reference Citation Analysis]
4 Hey-Hadavi J, Seekins D, Palmer M, Coffey D, Caminis J, Abdullaev S, Patwardhan M, Tyler H, Raheja R, Stanley AM, Pineda-Salgado L, Bourdet DL, Andrade RJ, Hayashi PH, Dimick-Santos L, Rockey DC, Estilo A. Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. Drug Saf 2021;44:619-34. [PMID: 33725335 DOI: 10.1007/s40264-021-01051-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhao SX, Zhang QS, Kong L, Zhang YG, Wang RQ, Nan YM, Kong LB. Dichlorvos induced autoimmune hepatitis: a case report and review of literature. Hepat Mon 2015;15:e25469. [PMID: 26034503 DOI: 10.5812/hepatmon.25469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671-722. [PMID: 31863477 DOI: 10.1002/hep.31065] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 104.0] [Reference Citation Analysis]
7 Dalekos GN, Koskinas J, Papatheodoridis GV. Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis. Ann Gastroenterol 2019;32:1-23. [PMID: 30598587 DOI: 10.20524/aog.2018.0330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Beuers U, Gershwin ME. Unmet challenges in immune-mediated hepatobiliary diseases. Clin Rev Allergy Immunol 2015;48:127-31. [PMID: 25820618 DOI: 10.1007/s12016-015-8484-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
9 Martínez-casas OY, Díaz-ramírez GS, Marín-zuluaga JI, Muñoz-maya O, Santos O, Donado-gómez JH, Restrepo-gutiérrez JC. Differential characteristics in drug-induced autoimmune hepatitis: Drug-induced autoimmune hepatitis. JGH Open 2018;2:97-104. [DOI: 10.1002/jgh3.12054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
10 Zhu J, Chen M, Borlak J, Tong W. The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitis.Arch Toxicol. 2020;94:273-293. [PMID: 31720699 DOI: 10.1007/s00204-019-02621-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Buechter M, Manka P, Heinemann FM, Lindemann M, Baba HA, Schlattjan M, Canbay A, Gerken G, Kahraman A. Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. World J Gastroenterol 2018; 24(13): 1410-1418 [PMID: 29632422 DOI: 10.3748/wjg.v24.i13.1410] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
12 Andrade RJ, Robles-diaz M, Castiella A. Characterizing Drug-Induced Liver Injury With Autoimmune Features. Clinical Gastroenterology and Hepatology 2016;14:1844-5. [DOI: 10.1016/j.cgh.2016.07.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
13 Magalhães R, Fonseca M, Brandão I, Caridade S. Autoimmune hepatitis unmasked by nimesulide. BMJ Case Rep 2016;2016:bcr2015212884. [PMID: 26791119 DOI: 10.1136/bcr-2015-212884] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Meunier L, Ursic-Bedoya J, Pageaux GP, Larrey D. Pantoprazole-induced autoimmune chronic hepatitis. Liver Int 2018;38:995-9. [PMID: 29532602 DOI: 10.1111/liv.13737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Benesic A, Leitl A, Gerbes AL. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury. Gut 2016;65:1555-63. [PMID: 26045135 DOI: 10.1136/gutjnl-2015-309528] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
17 Slim M, Medina-Caliz I, Gonzalez-Jimenez A, Cabello MR, Mayoral-Cleries F, Lucena MI, Andrade RJ. Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. Drug Saf 2016;39:925-43. [PMID: 27449495 DOI: 10.1007/s40264-016-0436-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
18 Alqrinawi SH, Akbar N, AlFaddag H, Akbar S, Akbar L, Butt SA, Aljawad M. Menotrophin Induced Autoimmune Hepatitis. Case Rep Gastrointest Med 2019;2019:7343805. [PMID: 31565446 DOI: 10.1155/2019/7343805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Floreani A, Restrepo-jiménez P, Secchi MF, De Martin S, Leung PS, Krawitt E, Bowlus CL, Gershwin ME, Anaya J. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 2018;95:133-43. [DOI: 10.1016/j.jaut.2018.10.020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 14.7] [Reference Citation Analysis]
20 Lin Z, Zhu B, Jin X. Onset of HLA-B27-associated diseases in diabetic patient during a period of religious fasting: A case report. Medicine (Baltimore) 2018;97:e0104. [PMID: 29538202 DOI: 10.1097/MD.0000000000010104] [Reference Citation Analysis]
21 Tufoni M, Serena Ricci C, Zaccherini G. A Case of Immune-Mediated Liver Injury Induced by Olaparib. Hepatology 2018;68:2039-41. [PMID: 30070367 DOI: 10.1002/hep.30119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
22 Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep 2020;2:100149. [PMID: 32995712 DOI: 10.1016/j.jhepr.2020.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci. 2016;17. [PMID: 27187363 DOI: 10.3390/ijms17050714] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 7.6] [Reference Citation Analysis]
24 Covini G, Bredi E, Badalamenti S, Roncalli M, Aghemo A, Colombo M. Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report. Hepatol Commun 2018;2:1179-83. [PMID: 30288473 DOI: 10.1002/hep4.1248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
25 van Gemeren MA, van Wijngaarden P, Doukas M, de Man RA. Vaccine-related autoimmune hepatitis: the same disease as idiopathic autoimmune hepatitis? Two clinical reports and review. Scand J Gastroenterol. 2017;52:18-22. [PMID: 27565372 DOI: 10.1080/00365521.2016.1224379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
26 Kawabata H, Kawakatsu Y, Inoue N, Okazaki Y, Sone D, Yamaguchi K, Ueda Y, Hitomi M, Miyata M, Motoi S, Enoki Y, Minamikawa T. IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology. Intern Med 2020;59:1401-5. [PMID: 32475907 DOI: 10.2169/internalmedicine.4092-19] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Stephens C, Castiella A, Gomez-moreno EM, Otazua P, López-nevot M, Zapata E, Ortega-alonso A, Ruiz-cabello F, Medina-cáliz I, Robles-díaz M, Soriano G, Roman E, Hallal H, Moreno-planas JM, Prieto M, Andrade RJ, Lucena MI. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles. Pharmacogenetics and Genomics 2016;26:414-22. [DOI: 10.1097/fpc.0000000000000230] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.4] [Reference Citation Analysis]
28 Wu Y, Zhu J, Fu P, Tong W, Hong H, Chen M. Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose. Int J Environ Res Public Health 2021;18:7139. [PMID: 34281077 DOI: 10.3390/ijerph18137139] [Reference Citation Analysis]
29 Palmer M, Regev A, Lindor K, Avigan MI, Dimick-Santos L, Treem W, Marcinak JF, Lewis JH, Anania FA, Seekins D, Shneider BL, Chalasani N. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Aliment Pharmacol Ther. 2020;51:90-109. [PMID: 31762074 DOI: 10.1111/apt.15579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
30 Ortega-Alonso A, Andrade RJ. Chronic liver injury induced by drugs and toxins. J Dig Dis 2018;19:514-21. [PMID: 29808546 DOI: 10.1111/1751-2980.12612] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
31 Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol 2017; 23(33): 6137-6146 [PMID: 28970729 DOI: 10.3748/wjg.v23.i33.6137] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 69] [Article Influence: 20.0] [Reference Citation Analysis]
32 Raschi E, De Ponti F. Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk. World J Hepatol 2015; 7(13): 1761-1771 [PMID: 26167249 DOI: 10.4254/wjh.v7.i13.1761] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
33 Stine JG, Northup PG. Autoimmune-like drug-induced liver injury: a review and update for the clinician. Expert Opinion on Drug Metabolism & Toxicology 2016;12:1291-301. [DOI: 10.1080/17425255.2016.1211110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
34 Stephens C, Andrade RJ. Genetic Predisposition to Drug-Induced Liver Injury. Clin Liver Dis 2020;24:11-23. [PMID: 31753244 DOI: 10.1016/j.cld.2019.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
35 Guo L, Zhou L, Zhang N, Deng B, Wang B. Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists. Gastroenterol Res Pract 2017;2017:2376231. [PMID: 28191014 DOI: 10.1155/2017/2376231] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
36 Seife Hassen S, Ata F, Bint I Bilal A, Salih Ali M, Petkar M, Awad Elzouki AY, Zahid M. Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report. Clin Case Rep 2020;8:3421-6. [PMID: 33363945 DOI: 10.1002/ccr3.3421] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Enomoto H, Nishiguchi S. Similarities and Differences in Autoimmune Hepatitis Epidemiology between East and West: Autoimmune Hepatitis in East Asia, Southeast Asia, and South Asia. Inflamm Intest Dis 2017;1:150-8. [PMID: 29922671 DOI: 10.1159/000454879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Aivazian K, Long GV, Sinclair EC, Kench JG, McKenzie CA. Histopathology of pembrolizumab-induced hepatitis: a case report. Pathology 2017;49:789-92. [PMID: 29079004 DOI: 10.1016/j.pathol.2017.07.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
39 Kleiner DE. Histopathological challenges in suspected drug-induced liver injury. Liver Int 2018;38:198-209. [PMID: 28865179 DOI: 10.1111/liv.13584] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
40 Rangel MA, Pinto Pais I, Duarte R, Carvalho I. Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges. Case Rep Pediatr 2017;2017:5741896. [PMID: 28116201 DOI: 10.1155/2017/5741896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH; Drug-Induced Liver Injury Network. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol 2017;15:103-112.e2. [PMID: 27311619 DOI: 10.1016/j.cgh.2016.05.043] [Cited by in Crossref: 85] [Cited by in F6Publishing: 66] [Article Influence: 17.0] [Reference Citation Analysis]
42 . EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015;63:971-1004. [DOI: 10.1016/j.jhep.2015.06.030] [Cited by in Crossref: 489] [Cited by in F6Publishing: 399] [Article Influence: 81.5] [Reference Citation Analysis]
43 Björnsson ES. Autoimmune Hepatitis-Induced by Drugs: a Challenging Diagnosis. Curr Hepatology Rep 2017;16:265-70. [DOI: 10.1007/s11901-017-0365-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 2015; 21(1): 60-83 [PMID: 25574080 DOI: 10.3748/wjg.v21.i1.60] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 66] [Article Influence: 12.2] [Reference Citation Analysis]
45 Bhatty O, Selim M, Kassim T, Chintalacheruvu L, Urra M, Shah S, Haggerty J, Gross J, Jhand A, Pershwitz G, Gupta J. A Case of Imatinib-Induced Hepatitis. Cureus 2017;9:e1302. [PMID: 28690936 DOI: 10.7759/cureus.1302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Almeida J, Solà-Valls N, Pose E, Blanco Y, Sepúlveda M, Llufriu S, Gines P, Saiz A. Liver injury and glatiramer acetate, an uncommon association: case report and literature review. Ther Adv Neurol Disord 2017;10:367-72. [PMID: 29090021 DOI: 10.1177/1756285617722352] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Avigan MI, Muñoz MA. Perspectives on the Regulatory and Clinical Science of Drug-Induced Liver Injury (DILI). In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 367-93. [DOI: 10.1007/978-1-4939-7677-5_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
48 Das A, Guarda LA, Allen LG. Liver Injury Associated With Quetiapine: An Illustrative Case Report. J Clin Psychopharmacol 2017;37:623-5. [PMID: 28786826 DOI: 10.1097/JCP.0000000000000749] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Sánchez M, Castiella A, Zapata E, Zubiaurre L, Pérez-Yeboles J, Mendibil L, Iribarren A. Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin. Gastroenterol Hepatol 2018;41:311-3. [PMID: 28655408 DOI: 10.1016/j.gastrohep.2017.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]